Related Experiment Videos
Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic
E von Dobschuetz1, O Bleiziffer, S Pahernik
1Dept. of General and Visceral Surgery, Albert Ludwigs Univ., Hugstetter Str. 55, 79106 Freiburg, Germany. ernst@von-dobschuetz.de
American Journal of Physiology. Gastrointestinal and Liver Physiology
|December 25, 2003
Summary
Complement inhibition using recombinant soluble complement receptor 1 (sCR1) significantly reduces microvascular permeability and leukocyte interaction in postischemic pancreatitis. This approach improves functional capillary perfusion, offering a potential treatment for organ injury.
Area of Science:
- Immunology
- Physiology
- Medical Research
Background:
- Complement cascade activation contributes to organ injury following ischemia-reperfusion.
- Postischemic pancreatitis involves microcirculatory disturbances, including increased vascular permeability and leukocyte adhesion.
Purpose of the Study:
- To investigate the therapeutic effect of recombinant soluble complement receptor 1 (sCR1) on ischemia-reperfusion injury in the pancreas.
- To evaluate the impact of sCR1 on microvascular permeability, capillary perfusion, and leukocyte-endothelial interactions in postischemic pancreatitis.
Main Methods:
- Intravital epifluorescence microscopy was used in a rat model of pancreatic ischemia-reperfusion.
- Rats were subjected to 60 minutes of pancreatic ischemia followed by reperfusion.
- The effect of sCR1 administration during reperfusion was assessed on macromolecular permeability, functional capillary density, and leukocyte adhesion.
Main Results:
- sCR1 treatment significantly reduced macromolecular microvascular permeability compared to vehicle-treated controls.
- Functional capillary density was significantly improved in sCR1-treated rats.
- Leukocyte adhesion to postcapillary venules was significantly reduced by sCR1 administration.
Conclusions:
- Complement inhibition with sCR1 effectively ameliorates microcirculatory disturbances in postischemic pancreatitis.
- sCR1 demonstrates therapeutic potential for treating ischemia-reperfusion-induced organ injury, specifically in the context of pancreatitis.